EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Respiratory Research

ISSN 1465-993X · Springer Science and Business Media LLC

Latest articles

  1. From ex vivo personalized theratyping to in vivo validation: unmasking next-generation vanzacaftor-tezacaftor efficacy in the ETI-resistant H147P-CFTR variant

    Emanuela Pesce, Marica Bordicchia, Valeria Capurro, Cristina Pastorino, Nicole Caporelli, Federico Cresta, Alice Mantero, Aurora Borasi, Valeria Tomati, Raffaele Pisani, Silviana Timpano, Rosaria Casciaro, Vito Terlizzi, Donatello Salvatore, Federico Zara, Angela Pepe, Carlo Castellani, Benedetta Fabrizzi, Nicoletta Pedemonte

    Published: 2026-11-18DOI: 10.1186/s12931-026-03989-5

  2. Integrative multi-omics analysis identifies molecular signatures associated with high-risk of systemic reactions to honeybee venom and olive pollen

    María Isabel Delgado-Dolset, María José Rodríguez Sánchez, Silvia Garcés-Rigol, Mayte Villalba, Domingo Barber, María M. Escribese, Paloma Fernández Martínez, Sara Mayor, Blanca Raposo-Martínez, Ana Navas, Aurora Jurado, Coral Barbas, Alma Villaseñor, Manuel Martí, Carmen Rondon, Cristobalina Mayorga, María José Torres, María Salas, Berta Ruiz-León, Juan Carlos López-Rodríguez, Pilar Serrano, Alba Rodríguez Nogales

    Published: 2026-11-03DOI: 10.1186/s12931-026-03978-8

  3. Elarekibep, an inhaled Anticalin protein, targets IL-4Rα locally: first-in-human randomized phase 1 trials of a novel potential therapeutic class in asthma

    Ingmar B. Bruns, Jason D. Lickliter, Kayti Aviano, Mary F. Fitzgerald, George Mensing, Mei Jen Tsung, Erol Wiegert, Katerina Pardali, Philip Gardiner, Robert Palmér, Glen Hughes, Marita Olsson, Tania Hugo, Christina Keen, Therese Lood, Fanyi Jiang, David J. Keeling, Lena T. Axelsson, Cyrus Ghobadi, Kristi McLendon, Nicholas Farinola, Lara Hatchuel, David R. Close

    Published: 2026-08-19DOI: 10.1186/s12931-026-03854-5

Volumes

2026 · 5202025 · 3862024 · 4482023 · 3202022 · 3822021 · 3232020 · 3312019 · 2932018 · 2622017 · 2182016 · 1662015 · 1562014 · 1382013 · 832012 · 652011 · 1612010 · 1842009 · 1282008 · 842007 · 932006 · 1472005 · 1532004 · 292003 · 152002 · 232001 · 1672000 · 63

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.